MEF2C and embryonal carcinoma: For instance, overexpression of GATA4, NKX2. 5, or MEF2C can enhance cardiomyogenic differentiation of P19 murine embryonic carcinoma [24, 50], yet they do so at differing efficiencies, indicating that their ability to induce cardiogenesis likely depends on the disposition of additional regulatory factors [50].